Experienced in Age-Related Macular Degeneration (ARMD)

Satoshi Inoue

Hamamatsu, JP 
Experienced in Age-Related Macular Degeneration (ARMD)
Hamamatsu, JP 
OverviewLocationsClinical Research

Overview

Satoshi Inoue practices in Hamamatsu, Japan. Mr. Inoue is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Bladder Cancer, Rabies, Prostate Cancer, Oophorectomy, and Thrombectomy.

His clinical research consists of co-authoring 592 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Age-Related Macular Degeneration (ARMD).

Gender
Male

Locations

Hamamatsu, Japan
Other Locations
Japan
Osaka, Japan
Tokyo, Japan
Hidaka, Japan
Nagoya, Japan
Itabashi, 1730015, Japan
Sendai, 9808577, Japan
Kakogawa, 6750122, Japan
Kurashiki, Japan
Toyama, Japan
Kyoto, Japan
Shinjuku, 1628640, Japan
Inoue, Japan
Tsukuba, 3002635, Japan
Morioka, 0208550, Japan
Saitama, Japan
Hatanodai, 1428555, Japan
Naka, 3110193, Japan
Okazaki, Japan
Suita, 5650853, Japan
Yamato, Japan
Sapporo, 0608586, Japan
Chiba, Japan
Miyazaki, Japan
Okayama, Japan
Gifu-shi, Japan
Musashimurayama, 2080011, Japan
Aomori, Japan
Nagakute, 4801195, Japan
Sugano, 2728513, Japan
Nishi, 8190032, Japan
Saga, Japan
Kitanagase, 7008557, Japan
Hiroshima, Japan
Kobe, Japan
Wakayama, Japan
Itabashi, Japan
Hiratsuka, 2591293, Japan
Yamanashi, Japan
Nabeshima, 8498501, Japan
Toyota, Japan
Fukushima, Japan
Hidaka, Japan
Himeji, 6712201, Japan
Nomi, 9231211, Japan
Showa, Japan
Mitsuishi-honcho, 0593105, Japan
Iruma, 3500495, Japan
Toyoake, 4701192, Japan
Nagasaki, Japan
Hongo, 1138655, Japan
Fujisawa, Japan
Yokohama, 2360004, Japan
Shizuoka, Japan
Kitami, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Drug: LY3561774
Study Phase: Phase 2
Efficacy and Safety of Once-Weekly Tirzepatide in Participants With Obesity Disease: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-J)
Efficacy and Safety of Once-Weekly Tirzepatide in Participants With Obesity Disease: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-J)
Enrollment Status: Completed
Publish Date: July 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Two Doses of Dulaglutide in Combination With a Single Oral Antihyperglycemic Medication or as Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus (AWARD-JPN: Assessment of Weekly Administration of LY2189265 in Diabetes - JAPAN)
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Two Doses of Dulaglutide in Combination With a Single Oral Antihyperglycemic Medication or as Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus (AWARD-JPN: Assessment of Weekly Administration of LY2189265 in Diabetes - JAPAN)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Drug
Study Drugs: Dulaglutide, Biguanide (BG), Sulfonylurea (SU), Alpha-Glucosidase Inhibitors (?-GI), Thiazolidinedione (TZD), Glinides (GLN), Sodium-Glucose Cotransporter Type 2 Inhibitors (SGLT2i)
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus
A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: August 22, 2022
Intervention Type: Drug
Study Drug: LY3437943
Study Phase: Phase 1
A Phase 3 Study of Tirzepatide Monotherapy Compared to Dulaglutide 0.75 mg in Patients With Type 2 Diabetes Mellitus
A Phase 3 Study of Tirzepatide Monotherapy Compared to Dulaglutide 0.75 mg in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: April 14, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

592 Total Publications

Effectiveness of Opioid Titration for Terminal Dyspnea in Opioid-Naïve and -Tolerant Patients with Advanced Cancer: A Multicenter Prospective Cohort Study.
Effectiveness of Opioid Titration for Terminal Dyspnea in Opioid-Naïve and -Tolerant Patients with Advanced Cancer: A Multicenter Prospective Cohort Study.
Journal: Journal of palliative medicine
Published: November 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Inoue's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 119 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile